NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|17564342|ref|NP_506520|]
View 

Neprilysin-21 [Caenorhabditis elegans]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
106-767 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 657.13  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 106 INPCEDFYEFACGNYGLNKNLPANKPLRHTISDVQSRLNKQVKSMLQSPIS-ANEKPWDKVAKGYYQKCLDEEELESTGV 184
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASsAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 185 EAMRDIAKRIGGWPTLEGDkwqewshsWEEQIALVLNLTGVNaVILEMAVTHDPSNSSRSVIELDQPKWGAGSRYPYLSG 264
Cdd:cd08662  81 KPLKPLLDKIGGLPSLDDL--------AAELLLALLRRLGVS-LLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 265 ANDPMLRNYTTLMKMTAVALGADPAIAEKEMNEAMEFELKLVNFSADDMVRRDPERGNNRFELWQLKSVFPFINFEKYLK 344
Cdd:cd08662 152 ENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLAPSIDWKAYLK 231
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 345 TVFKELvalSPNHTVIVREIDYFVGIQHVLQSTPKRVLANYISWRLVQGFSPFLPPSAREPFYQFkaNQTGMFNSPPPDR 424
Cdd:cd08662 232 ALGPPA---DDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFY--GKALSGQKEPEPR 306
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 425 WEDCVTLSVIMMDMPVGRLFVENFFEKErAMKKMTELTSYLKNEFIKQLHVLDWMDEITRRRAISKANMIEYKSGFPMVL 504
Cdd:cd08662 307 WKRCVELVNGALGEALGRLYVEKYFSEE-AKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKW 385
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 505 FNDTWMEKNWGMIIKPREYLlHLTIRVKLVRFTEELLRLDQPLDRSMWFQSPAQVDAYYAPNNNEMIFPAGIMQFPFLTL 584
Cdd:cd08662 386 RDYSALDIYYDDLNVSDSYF-ENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDP 464
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 585 GVPNYITYGMVGAVIGHEVSHAFDDQGGQYDEMGNLNDWWDAETEEKFIEKTRCFVRQYENVhVVEADIHLNGQLSLGEN 664
Cdd:cd08662 465 DAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNY-EVPPGLHVNGKLTLGEN 543
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 665 IADNGGVKTAFNAYKAWKSNttgiSEPALPGFQNFTSQQMFFLAYANNWCSLVRPKHYIQIILTDVHAPSKYRAMIPLQN 744
Cdd:cd08662 544 IADNGGLRLAYRAYKKWLKE----NGPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSN 619
                       650       660
                ....*....|....*....|...
gi 17564342 745 RPEFAKAFQCPIGSPMNPERKCQ 767
Cdd:cd08662 620 SPEFAEAFNCPPGSPMNPEKKCR 642
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
106-767 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 657.13  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 106 INPCEDFYEFACGNYGLNKNLPANKPLRHTISDVQSRLNKQVKSMLQSPIS-ANEKPWDKVAKGYYQKCLDEEELESTGV 184
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASsAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 185 EAMRDIAKRIGGWPTLEGDkwqewshsWEEQIALVLNLTGVNaVILEMAVTHDPSNSSRSVIELDQPKWGAGSRYPYLSG 264
Cdd:cd08662  81 KPLKPLLDKIGGLPSLDDL--------AAELLLALLRRLGVS-LLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 265 ANDPMLRNYTTLMKMTAVALGADPAIAEKEMNEAMEFELKLVNFSADDMVRRDPERGNNRFELWQLKSVFPFINFEKYLK 344
Cdd:cd08662 152 ENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLAPSIDWKAYLK 231
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 345 TVFKELvalSPNHTVIVREIDYFVGIQHVLQSTPKRVLANYISWRLVQGFSPFLPPSAREPFYQFkaNQTGMFNSPPPDR 424
Cdd:cd08662 232 ALGPPA---DDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFY--GKALSGQKEPEPR 306
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 425 WEDCVTLSVIMMDMPVGRLFVENFFEKErAMKKMTELTSYLKNEFIKQLHVLDWMDEITRRRAISKANMIEYKSGFPMVL 504
Cdd:cd08662 307 WKRCVELVNGALGEALGRLYVEKYFSEE-AKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKW 385
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 505 FNDTWMEKNWGMIIKPREYLlHLTIRVKLVRFTEELLRLDQPLDRSMWFQSPAQVDAYYAPNNNEMIFPAGIMQFPFLTL 584
Cdd:cd08662 386 RDYSALDIYYDDLNVSDSYF-ENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDP 464
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 585 GVPNYITYGMVGAVIGHEVSHAFDDQGGQYDEMGNLNDWWDAETEEKFIEKTRCFVRQYENVhVVEADIHLNGQLSLGEN 664
Cdd:cd08662 465 DAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNY-EVPPGLHVNGKLTLGEN 543
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 665 IADNGGVKTAFNAYKAWKSNttgiSEPALPGFQNFTSQQMFFLAYANNWCSLVRPKHYIQIILTDVHAPSKYRAMIPLQN 744
Cdd:cd08662 544 IADNGGLRLAYRAYKKWLKE----NGPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSN 619
                       650       660
                ....*....|....*....|...
gi 17564342 745 RPEFAKAFQCPIGSPMNPERKCQ 767
Cdd:cd08662 620 SPEFAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
86-769 4.78e-139

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 425.34  E-value: 4.78e-139
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342  86 CTSRECVRLAGFLAENLNSKINPCEDFYEFACGNYgLNKN-LPANKPLRHTISDVQSRLNKQVKSMLQSpISANEKPWDK 164
Cdd:COG3590  17 CAAAAAAGTSGIDLANMDTSVRPGDDFYRYVNGGW-LKTTpIPADRSRWGSFNELRERNEARLRAILEE-AAAAPAAAGS 94
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 165 VAK---GYYQKCLDEEELESTGVEAMRDIAKRIGGWPTLEgdkwqewshsweEQIALV--LNLTGVNAVIlEMAVTHDPS 239
Cdd:COG3590  95 DEQkigDLYASFMDEAAIEALGLAPLKPDLARIDAIKDKA------------DLAALLaaLHRAGVGGLF-GFGVDADLK 161
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 240 NSSRSVIELDQPKWGAGSR-YpYLSG--ANDPMLRNYTTLMKMTAVALGADPAIAEKEMNEAMEFELKLVNFSADDMVRR 316
Cdd:COG3590 162 NSTRYIAYLGQGGLGLPDRdY-YLKDdeKSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSRVELR 240
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 317 DPERGNNRFELWQLKSVFPFINFEKYLKTVFKELVAlspnhTVIVREIDYFVGIQHVLQSTPKRVLANYISWRLVQGFSP 396
Cdd:COG3590 241 DPEKTYNPMTVAELAKLAPGFDWDAYLKALGLPAVD-----EVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAP 315
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 397 FLPpsarEPFYQ--FKANQTGMFNSP-PPDRWEDCVTLSVIMMDMPVGRLFVENFFeKERAMKKMTELTSYLKNEFIKQL 473
Cdd:COG3590 316 YLS----KAFVDanFDFYGKTLSGQKeQRPRWKRAVALVNGALGEALGQLYVERYF-PPEAKARMEELVANLRAAYRERI 390
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 474 HVLDWMDEITRRRAISKANMIEYKSGFPmvlfnDTWmeKNW-GMIIKPREYLLHLtIRVKLVRFTEELLRLDQPLDRSMW 552
Cdd:COG3590 391 ENLDWMSPETKAKALEKLAAFTPKIGYP-----DKW--RDYsGLEIKRDDLVGNV-LRASAFEYQRELAKLGKPVDRTEW 462
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 553 FQSPAQVDAYYAPNNNEMIFPAGIMQFPFLTLGVPNYITYGMVGAVIGHEVSHAFDDQGGQYDEMGNLNDWWDAETEEKF 632
Cdd:COG3590 463 GMTPQTVNAYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAF 542
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 633 IEKTRCFVRQYENVHVVEaDIHLNGQLSLGENIADNGGVKTAFNAYKAWKSnttGISEPALPGfqnFTSQQMFFLAYANN 712
Cdd:COG3590 543 EARTKKLVAQYDAYEPLP-GLHVNGKLTLGENIADLGGLSIAYDAYKLSLK---GKEAPVIDG---FTGDQRFFLGWAQV 615
                       650       660       670       680       690
                ....*....|....*....|....*....|....*....|....*....|....*....
gi 17564342 713 WCSLVRPKHYIQIILTDVHAPSKYRAMIPLQNRPEFAKAFQCPIGSPM--NPERKCQVW 769
Cdd:COG3590 616 WRSKARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
108-501 1.53e-95

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 302.30  E-value: 1.53e-95
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342   108 PCEDFYEFACGNYGLNKNLPANKPLRHTISDVQSRLNKQVKSMLQSPI-SANEKPWDKVAKGYYQKCLDEEELESTGVEA 186
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAaSESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342   187 MRDIAKRIGGWPtlegdkWQEWSHSWEEQIALvLNLTGVNaVILEMAVTHDPSNSSRSVIELDQPKWGAGSRYPYLSGAN 266
Cdd:pfam05649  81 LKPLLDEIGGPL------ANKDKFDLLETLAK-LRRYGVD-SLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYLKDRD 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342   267 DPM---LRNYTTLMKMTAVALGADPAiAEKEMNEAMEFELKLVNFSADDMVRRDPERGNNRFELWQLKSVFPFINFEKYL 343
Cdd:pfam05649 153 EKSaeiREAYKAYIAKLLTLLGASEE-AAALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQKLAPGIDWKAYL 231
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342   344 KtvfKELVALSPNHTVIVREIDYFVGIQHVLQSTPKRVLANYISWRLVQGFSPFLPPSAREPFYQFKANQTGmfnSPPPD 423
Cdd:pfam05649 232 N---AAGLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTLSG---TKQRP 305
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 17564342   424 RWEDCVTLSVIMMDMPVGRLFVENFFEKErAMKKMTELTSYLKNEFIKQLHVLDWMDEITRRRAISKANMIEYKSGFP 501
Cdd:pfam05649 306 RWKRCVSLVNGLLGEALGRLYVKKYFPEE-AKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTVKIGYP 382
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
106-767 0e+00

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 657.13  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 106 INPCEDFYEFACGNYGLNKNLPANKPLRHTISDVQSRLNKQVKSMLQSPIS-ANEKPWDKVAKGYYQKCLDEEELESTGV 184
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHPIPADKSSWGSFSELQDRNEEQLREILEEAASsAADSSAEQKAKDFYKSCMDEEAIEKLGL 80
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 185 EAMRDIAKRIGGWPTLEGDkwqewshsWEEQIALVLNLTGVNaVILEMAVTHDPSNSSRSVIELDQPKWGAGSRYPYLSG 264
Cdd:cd08662  81 KPLKPLLDKIGGLPSLDDL--------AAELLLALLRRLGVS-LLFGLGVSPDPKNSSRNILYLGQPGLGLPDRDYYLDE 151
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 265 ANDPMLRNYTTLMKMTAVALGADPAIAEKEMNEAMEFELKLVNFSADDMVRRDPERGNNRFELWQLKSVFPFINFEKYLK 344
Cdd:cd08662 152 ENAEIREAYKKYIAKLLELLGADEEEAEKLAEDVLAFETELAKISLSSEELRDPEKTYNPLTLAELQKLAPSIDWKAYLK 231
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 345 TVFKELvalSPNHTVIVREIDYFVGIQHVLQSTPKRVLANYISWRLVQGFSPFLPPSAREPFYQFkaNQTGMFNSPPPDR 424
Cdd:cd08662 232 ALGPPA---DDPDKVIVSQPEYLKKLDKLLASTPLRTLKNYLIWRLLDSLAPYLSKEFRDARFFY--GKALSGQKEPEPR 306
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 425 WEDCVTLSVIMMDMPVGRLFVENFFEKErAMKKMTELTSYLKNEFIKQLHVLDWMDEITRRRAISKANMIEYKSGFPMVL 504
Cdd:cd08662 307 WKRCVELVNGALGEALGRLYVEKYFSEE-AKADVEEMVENIKEAFKERLENLDWMDEETKKKALEKLDAMKVKIGYPDKW 385
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 505 FNDTWMEKNWGMIIKPREYLlHLTIRVKLVRFTEELLRLDQPLDRSMWFQSPAQVDAYYAPNNNEMIFPAGIMQFPFLTL 584
Cdd:cd08662 386 RDYSALDIYYDDLNVSDSYF-ENVLRLLRFETKRQLAKLGKPVDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDP 464
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 585 GVPNYITYGMVGAVIGHEVSHAFDDQGGQYDEMGNLNDWWDAETEEKFIEKTRCFVRQYENVhVVEADIHLNGQLSLGEN 664
Cdd:cd08662 465 DAPDALNYGGIGAVIGHEITHGFDDQGRQYDENGNLRNWWTNEDRKEFEERAQCLVDQYSNY-EVPPGLHVNGKLTLGEN 543
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 665 IADNGGVKTAFNAYKAWKSNttgiSEPALPGFQNFTSQQMFFLAYANNWCSLVRPKHYIQIILTDVHAPSKYRAMIPLQN 744
Cdd:cd08662 544 IADNGGLRLAYRAYKKWLKE----NGPELPGLEGFTPEQLFFLSFAQVWCSKYRPEALRQLLLTDPHSPGKFRVNGPLSN 619
                       650       660
                ....*....|....*....|...
gi 17564342 745 RPEFAKAFQCPIGSPMNPERKCQ 767
Cdd:cd08662 620 SPEFAEAFNCPPGSPMNPEKKCR 642
PepO COG3590
Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];
86-769 4.78e-139

Predicted metalloendopeptidase [Posttranslational modification, protein turnover, chaperones];


Pssm-ID: 442809 [Multi-domain]  Cd Length: 674  Bit Score: 425.34  E-value: 4.78e-139
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342  86 CTSRECVRLAGFLAENLNSKINPCEDFYEFACGNYgLNKN-LPANKPLRHTISDVQSRLNKQVKSMLQSpISANEKPWDK 164
Cdd:COG3590  17 CAAAAAAGTSGIDLANMDTSVRPGDDFYRYVNGGW-LKTTpIPADRSRWGSFNELRERNEARLRAILEE-AAAAPAAAGS 94
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 165 VAK---GYYQKCLDEEELESTGVEAMRDIAKRIGGWPTLEgdkwqewshsweEQIALV--LNLTGVNAVIlEMAVTHDPS 239
Cdd:COG3590  95 DEQkigDLYASFMDEAAIEALGLAPLKPDLARIDAIKDKA------------DLAALLaaLHRAGVGGLF-GFGVDADLK 161
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 240 NSSRSVIELDQPKWGAGSR-YpYLSG--ANDPMLRNYTTLMKMTAVALGADPAIAEKEMNEAMEFELKLVNFSADDMVRR 316
Cdd:COG3590 162 NSTRYIAYLGQGGLGLPDRdY-YLKDdeKSAEIRAAYVAHVAKMLELAGYDEADAAAAAEAVLALETALAKAHWSRVELR 240
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 317 DPERGNNRFELWQLKSVFPFINFEKYLKTVFKELVAlspnhTVIVREIDYFVGIQHVLQSTPKRVLANYISWRLVQGFSP 396
Cdd:COG3590 241 DPEKTYNPMTVAELAKLAPGFDWDAYLKALGLPAVD-----EVIVGQPSFFKALDKLLASTPLEDWKAYLRWHLLDSAAP 315
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 397 FLPpsarEPFYQ--FKANQTGMFNSP-PPDRWEDCVTLSVIMMDMPVGRLFVENFFeKERAMKKMTELTSYLKNEFIKQL 473
Cdd:COG3590 316 YLS----KAFVDanFDFYGKTLSGQKeQRPRWKRAVALVNGALGEALGQLYVERYF-PPEAKARMEELVANLRAAYRERI 390
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 474 HVLDWMDEITRRRAISKANMIEYKSGFPmvlfnDTWmeKNW-GMIIKPREYLLHLtIRVKLVRFTEELLRLDQPLDRSMW 552
Cdd:COG3590 391 ENLDWMSPETKAKALEKLAAFTPKIGYP-----DKW--RDYsGLEIKRDDLVGNV-LRASAFEYQRELAKLGKPVDRTEW 462
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 553 FQSPAQVDAYYAPNNNEMIFPAGIMQFPFLTLGVPNYITYGMVGAVIGHEVSHAFDDQGGQYDEMGNLNDWWDAETEEKF 632
Cdd:COG3590 463 GMTPQTVNAYYNPTMNEIVFPAAILQPPFFDPKADDAVNYGGIGAVIGHEITHGFDDQGSQFDGDGNLRNWWTPEDRAAF 542
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342 633 IEKTRCFVRQYENVHVVEaDIHLNGQLSLGENIADNGGVKTAFNAYKAWKSnttGISEPALPGfqnFTSQQMFFLAYANN 712
Cdd:COG3590 543 EARTKKLVAQYDAYEPLP-GLHVNGKLTLGENIADLGGLSIAYDAYKLSLK---GKEAPVIDG---FTGDQRFFLGWAQV 615
                       650       660       670       680       690
                ....*....|....*....|....*....|....*....|....*....|....*....
gi 17564342 713 WCSLVRPKHYIQIILTDVHAPSKYRAMIPLQNRPEFAKAFQCPIGSPM--NPERKCQVW 769
Cdd:COG3590 616 WRSKARDEALRQRLATDPHSPGEFRVNGPVRNLDAFYEAFDVKPGDKMylAPEDRVRIW 674
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
108-501 1.53e-95

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 302.30  E-value: 1.53e-95
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342   108 PCEDFYEFACGNYGLNKNLPANKPLRHTISDVQSRLNKQVKSMLQSPI-SANEKPWDKVAKGYYQKCLDEEELESTGVEA 186
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHPIPADKSSWGTFDELRERNEKQLREILEEAAaSESDPGAVEKAKDLYKSCMDTDAIEKLGLKP 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342   187 MRDIAKRIGGWPtlegdkWQEWSHSWEEQIALvLNLTGVNaVILEMAVTHDPSNSSRSVIELDQPKWGAGSRYPYLSGAN 266
Cdd:pfam05649  81 LKPLLDEIGGPL------ANKDKFDLLETLAK-LRRYGVD-SLFGFGVGPDDKNSSRNILYLDQPGLGLPDRDYYLKDRD 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342   267 DPM---LRNYTTLMKMTAVALGADPAiAEKEMNEAMEFELKLVNFSADDMVRRDPERGNNRFELWQLKSVFPFINFEKYL 343
Cdd:pfam05649 153 EKSaeiREAYKAYIAKLLTLLGASEE-AAALAEEVLAFETKLAKASLSREERRDPEKTYNPMTLAELQKLAPGIDWKAYL 231
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342   344 KtvfKELVALSPNHTVIVREIDYFVGIQHVLQSTPKRVLANYISWRLVQGFSPFLPPSAREPFYQFKANQTGmfnSPPPD 423
Cdd:pfam05649 232 N---AAGLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKNYLIWRLVRSLAPYLSDEFRDANFEFYGTLSG---TKQRP 305
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 17564342   424 RWEDCVTLSVIMMDMPVGRLFVENFFEKErAMKKMTELTSYLKNEFIKQLHVLDWMDEITRRRAISKANMIEYKSGFP 501
Cdd:pfam05649 306 RWKRCVSLVNGLLGEALGRLYVKKYFPEE-AKARVEELVENIKEAFRERLDELDWMDEETKKKALEKLDAMTVKIGYP 382
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
561-768 1.76e-75

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 243.09  E-value: 1.76e-75
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342   561 AYYAPNNNEMIFPAGIMQFPFLTLGVPNYITYGMVGAVIGHEVSHAFDDQGGQYDEMGNLNDWWDAETEEKFIEKTRCFV 640
Cdd:pfam01431   2 AYYQPNRNEIVFPAAILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGAQFDKDGNLRSWWTDEDAEEFKDRAQCLI 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 17564342   641 RQYENVHVVEADIHLNGQLSLGENIADNGGVKTAFNAYKawksNTTGISEPALPGFQNFTSQQMFFLAYANNWCSLVRPK 720
Cdd:pfam01431  82 EQYSEYTPPDGTKCANGTLTLGENIADLGGLTIALRAYK----KLLSANETVLPGFENLTPDQLFFRGAAQIWCMKQSPA 157
                         170       180       190       200
                  ....*....|....*....|....*....|....*....|....*...
gi 17564342   721 HYIQIILTDVHAPSKYRAMIPLQNRPEFAKAFQCPIGSPMNPERKCQV 768
Cdd:pfam01431 158 EVLRQLLVDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRCRL 205
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
553-615 2.59e-03

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 38.23  E-value: 2.59e-03
                        10        20        30        40        50        60
                ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 17564342 553 FQSPAQVDAYYAPNNNeMIFPAGIMQfpfltlgvpnyiTYGMVGAVIGHEVSHAFDDQGGQYD 615
Cdd:cd09594  36 YVEVNAYNAMWIPSTN-IFYGAGILD------------TLSGTIDVLAHELTHAFTGQFSNLM 85
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH